1,453
Views
37
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Enhanced skin delivery of aceclofenac via hydrogel-based solid lipid nanoparticles

, , &
Pages 1434-1439 | Received 02 Jan 2015, Accepted 30 Mar 2015, Published online: 28 Apr 2015

References

  • Alvarez-Roman R, Naik A, Kalia YN, Fessi S, Guy RH. 2004. Visualisation of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm. 58:301–306.
  • Beaulieu AD, Peloso PM, Haraoui B, Bensen W, Thomson G, Wade J, et al. 2008. Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: A randomized controlled trial. Pain Res Manage. 13:103–110.
  • Bunjes H, Westensen K, Koch MHJ. 1996. Crystallization tendency and polymorphic transition in triglyceride nanoparticles. Int J Pharm. 129:159–173.
  • Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. 2005. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm. 304:231–238.
  • Chakraborty S, Khandai M, Sharma A, Khanam N, Patra CN, Dinda SC, Sen KK. 2010. Preparation, in vitro and in vivo evaluation of algino-pectinate bioadhesive microspheres: an investigation of the effects of polymers using multiple comparison analysis. Acta Pharm. 60:255.
  • Chawla V, Saraf SA. 2012. Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac. Coll Sur B: Biointerfaces. 92:293–298.
  • Chen H, Chang X, Du D, Liu W, Liu J, Weng T, et al. 2006. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Rel. 110:296–306.
  • de Vringer T, de Ronde HAG. 1995. Preparation and structure of water in oil cream containing lipid nanoparticles. J Pharm Sci. 84:466–472.
  • Dua K, Pabreja K, Ramana MV. 2010. Aceclofenac topical dosage forms: in vitro and in vivo characterization. Acta Pharm. 60:467.
  • Dubey V, Mishra D, Asthana A, Jain NK. 2006. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 27:3491–3496.
  • Hou Z, Xie C, Haung K, Zha C. 2003. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 24:1781–1785.
  • Jayaraman CS, Ramachandran C, Weiner N. 1996. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse skin. J Pharm Sci. 85:1082–1085.
  • Jenning V, Gohla S. 2001. Encapsulation of retinoids in solid lipid nanoparticles. J. Microencap.18:149–158.
  • Jenning V, Gysler A, Schafer-Korting M, Gohla SH. 2000. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 49:211–218.
  • Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. 2007. Isotretinoin-loaded solid lipid nanoparticle with skin targeting for topical delivery. Int J Pharm. 328:191–195.
  • Lopes LB, Ferreira DA, Poula D, Garcia MJ, Thiomazini JA, Fantini MA, Bentley MB. 2006. Reverse hexagonal nanodispersion of monoolean and oleic acid for topical delivery of triptolide: in vitro and in vivo skin penetration of cyclosporine A. Pharm Res. 23:1332–1342.
  • Luo Y, Chen D, Ren L, Zhao X, Qin J. 2006. Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Rel. 114:53–59.
  • Mai CS, Mehnert W, Schäfer-Korting M. 2000. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm. 196:165–167.
  • Mei Z, Wu Q, Hu S, Li X, Yang X. 2005. Triptolide loaded solid lipid nanoparticle hydrogel for topical application. Drug Develop Ind Pharm. 31:161–168.
  • Muller RH, Mehnert W, Lucks JS, Schuwarz C, Muhlen ZA, Weyners H, et al. 1995. Solid lipid nanoparticles (SLN) an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm. 41:62–69.
  • Muller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carrier (NLC) in cosmectic and dermatological preparation. Adv Drug Deliv Rev. 54:S131–135.
  • Musmade P, Subramanian G, Srinivasan KK. 2007. High performance thin layer chromatography and pharmacokinetic of aceclofenac in rats. Analytica Chem Acta. 585:1082–1085.
  • Pareek A, Chandurkar N, Gupta A, Sirsikar A, Dalal B, Jesalpura B, et al. 2011. Efficacy and Safety of Aceclofenac-CR and Aceclofenac in the Treatment of Knee Osteoarthritis: A 6-Week, Comparative, Randomized, Multicentric, Double-Blind Study. The J Pain.12:546–553.
  • Puglia C, Bonina F, Rizza L, Blasi P, Schoubben A, Perrotta R, et al. 2012. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies. J Pharma Sciences. 101:301–311.
  • Rowe RC, Shesky PJ, Weller PJ. 2002. Glyceryl monostearate. In: Rowe RC, Sheskey PJ, Cook WG, et al. Handbook of Pharmaceutical Excipient, 4th Ed. New York: Pharmaceutical Press, pp. 264–265.
  • Schatzlein A, Leve G. 1998. Non uniform cellular packing of the stratum corneun and permeability barrier fuction of the intact skin, high resolution confocal scanning microscopy study using highly deformable vesicles (tranferosome). British J Dermat. 138:583–592.
  • Shah AK, Date AA, Joshi MD, Patravale VB. 2007. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 345:163–171.
  • Shakeel F, Baboota S, Ahuja A, Ali J, Aquil M, Shafiq S. 2007. Nanoemulsion as vehicles for transdermal delivery of acelofenac. AAPS Pharm SciTech. 8:E1–9.
  • Souto EB, Wissing SA, Barbosa CM, Muller RH. 2004a. Development of controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278:71–78.
  • Souto EB, Wissing SA, Barbosa CM, Muller RH. 2004b. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm. 58:83–90.
  • Winter CA. 1965. Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents. Nonsteroidal Anti-inflmmat Drug. 52:190–202.
  • Wissing A, Muller RH. 2002. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Rel. 81:225–233.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.